GenSight Biologics S.A.: GenSight Biologics Announces Publication of a Study of the Impact of LHON Disease on the Lives of Patients and Relatives in Journal of Neuro-Ophthalmology
Study is first of its kind to explore the impact of LHON on patients and their relatives in four different countries Study determined that the impact of LHON extends beyond vision-related
United Kingdom United States Clothilde Caillet Magali Taiel James Palmer Gensight Biologics Euronext
Source: finanznachrichten.de